The U.S. Food and Drug Administration said on Tuesday it had approved the first gene therapy for a rare and life-threatening ...

New research published in Brain, Behavior, and Immunity provides evidence that alcohol use disorder triggers a distinct type ...

AC Immune (ACIU) announced positive interim safety and efficacy results from the Phase 2 VacSYn trial of its wholly-owned ...

The FDA has granted approval to a new gene therapy for a rare immune disorder, the maker of which is notably not a drug ...

A common virus carried by most humans could trigger lupus, offering new clues for preventing and treating this dangerous ...

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease Results show, for the first time, that targeting underlying a-syn pathology with ...

The addition of ianalumab to eltrombopag significantly improved outcomes for patients with pretreated primary immune ...

A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...

Researchers have published a comprehensive review exploring the critical role of the "immune microenvironment" in the ...

Immune system disorders in children include primary (inherited) and secondary (acquired) immunodeficiencies, autoimmune diseases, atopic diseases, and immune-mediated inflammatory disorders. Share on ...